Login / Signup

What the Hel: recent advances in understanding rifampicin resistance in bacteria.

Petra SudzinováHana ŠanderováTomáš KovaľTereza SkálováNabajyoti BorahJarmila HnilicováTomáš KoubaJan DohnálekLibor Krásný
Published in: FEMS microbiology reviews (2022)
Rifampicin is a clinically important antibiotic that binds to, and blocks the DNA/RNA channel of bacterial RNA polymerase (RNAP). Stalled, nonfunctional RNAPs can be removed from DNA by HelD proteins; this is important for maintenance of genome integrity. Recently, it was reported that HelD proteins from high G + C Actinobacteria, called HelR, are able to dissociate rifampicin-stalled RNAPs from DNA and provide rifampicin resistance. This is achieved by the ability of HelR proteins to dissociate rifampicin from RNAP. The HelR-mediated mechanism of rifampicin resistance is discussed here, and the roles of HelD/HelR in the transcriptional cycle are outlined. Moreover, the possibility that the structurally similar HelD proteins from low G + C Firmicutes may be also involved in rifampicin resistance is explored. Finally, the discovery of the involvement of HelR in rifampicin resistance provides a blueprint for analogous studies to reveal novel mechanisms of bacterial antibiotic resistance.
Keyphrases
  • mycobacterium tuberculosis
  • pulmonary tuberculosis
  • circulating tumor
  • cell free
  • single molecule
  • gene expression
  • small molecule
  • genome wide
  • nucleic acid
  • oxidative stress
  • high throughput